10-K Filing

TENET HEALTHCARE CORP CIK: 70318 FY 2015

Filing Information

Form Type	10-K
Accession Number	`0001558370-16-003350`
Period End Date	20151231
Filing Date	20160222
Fiscal Year	2015
Fiscal Period	FY
XBRL Instance	thc-20151231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 93 Income Statement 108 Cash Flow Statement 135 Stockholders Equity 27 Comprehensive Income 29

Balance Sheet 93 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$852.00M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$887.00M	USD	Point-in-time
Property and equipment, accumulated depreciation and amortization (in dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.32B	USD	Point-in-time
Property and equipment, accumulated depreciation and amortization (in dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.48B	USD	Point-in-time
Other intangible assets, accumulated amortization (in dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$659.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$356.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.00M	USD	Point-in-time
Other intangible assets, accumulated amortization (in dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$630.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$364.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$113.00M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts ($887 at December 31, 2015 and $852 at December 31, 2014)	`AccountsReceivableNetCurrent`	$2.70B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts ($887 at December 31, 2015 and $852 at December 31, 2014)	`AccountsReceivableNetCurrent`	$2.40B	USD	Point-in-time
Inventories of supplies, at cost	`InventoryNet`	$309.00M	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	262.50M	shares	Point-in-time
Inventories of supplies, at cost	`InventoryNet`	$276.00M	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	262.50M	shares	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$2.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	145.58M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	146.92M	shares	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$7.00M	USD	Point-in-time
Common stock in treasury, shares	`TreasuryStockShares`	47.20M	shares	Point-in-time
Common stock in treasury, shares	`TreasuryStockShares`	48.43M	shares	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$2.00M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$550.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.09B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.25B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.97B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.17B	USD	Point-in-time
Investments and other assets	`LongTermInvestmentsAndReceivablesNet`	$384.00M	USD	Point-in-time
Investments and other assets	`LongTermInvestmentsAndReceivablesNet`	$1.18B	USD	Point-in-time
Deferred income taxes, net of current portion	`DeferredTaxAssetsNetNoncurrent`	$863.00M	USD	Point-in-time
Deferred income taxes, net of current portion	`DeferredTaxAssetsNetNoncurrent`	$776.00M	USD	Point-in-time
Property and equipment, at cost, less accumulated depreciation and amortization ($4,323 at December 31, 2015 and $4,478 at December 31, 2014)	`PropertyPlantAndEquipmentNet`	$7.73B	USD	Point-in-time
Property and equipment, at cost, less accumulated depreciation and amortization ($4,323 at December 31, 2015 and $4,478 at December 31, 2014)	`PropertyPlantAndEquipmentNet`	$7.92B	USD	Point-in-time
Goodwill	`Goodwill`	$6.97B	USD	Point-in-time
Goodwill	`Goodwill`	$3.91B	USD	Point-in-time
Other intangible assets, at cost, less accumulated amortization ($659 at December 31, 2015 and $630 at December 31, 2014	`IntangibleAssetsNetExcludingGoodwill`	$1.68B	USD	Point-in-time
Other intangible assets, at cost, less accumulated amortization ($659 at December 31, 2015 and $630 at December 31, 2014	`IntangibleAssetsNetExcludingGoodwill`	$1.09B	USD	Point-in-time
Total assets	`Assets`	$23.68B	USD	Point-in-time
Total assets	`Assets`	$17.95B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$112.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$127.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.18B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.38B	USD	Point-in-time
Accrued compensation and benefits	`EmployeeRelatedLiabilitiesCurrent`	$852.00M	USD	Point-in-time
Accrued compensation and benefits	`EmployeeRelatedLiabilitiesCurrent`	$880.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveCurrent`	$189.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveCurrent`	$177.00M	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$205.00M	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$194.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$101.00M	USD	Point-in-time
Accrued legal settlement costs	`LitigationReserveCurrent`	$45.00M	USD	Point-in-time
Accrued legal settlement costs	`LitigationReserveCurrent`	$294.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.01B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.14B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.31B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.58B	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$11.51B	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$14.38B	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveNoncurrent`	$578.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveNoncurrent`	$492.00M	USD	Point-in-time
Defined benefit plan obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$633.00M	USD	Point-in-time
Defined benefit plan obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$595.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$558.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$594.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$16.77B	USD	Point-in-time
Total liabilities	`Liabilities`	$20.46B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$2.27B	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$401.00M	USD	Point-in-time
Common stock, $0.05 par value; authorized 262,500,000 shares; 146,920,454 shares issued at December 31, 2015 and 145,578,735 shares issued at December 31, 2014	`CommonStockValue`	$7.00M	USD	Point-in-time
Common stock, $0.05 par value; authorized 262,500,000 shares; 146,920,454 shares issued at December 31, 2015 and 145,578,735 shares issued at December 31, 2014	`CommonStockValue`	$7.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.61B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.82B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-182.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-164.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.55B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.41B	USD	Point-in-time
Common stock in treasury, at cost, 48,425,298 shares at December 31, 2015 and 47,196,902 shares at December 31, 2014	`TreasuryStockValue`	$2.38B	USD	Point-in-time
Common stock in treasury, at cost, 48,425,298 shares at December 31, 2015 and 47,196,902 shares at December 31, 2014	`TreasuryStockValue`	$2.42B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$691.00M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$651.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$267.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$134.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.22B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$958.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$785.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$878.00M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$17.95B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$23.68B	USD	Point-in-time

Income Statement 108 line items

Line Item	Tag	Value	Unit	Period
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$20.11B	USD	Annual
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$17.91B	USD	Annual
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$12.06B	USD	Annual
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.30B	USD	Annual
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.48B	USD	Annual
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$972.00M	USD	Annual
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$18.63B	USD	Annual
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$16.60B	USD	Annual
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$11.09B	USD	Annual
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$99.00M	USD	Annual
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$12.00M	USD	Annual
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$15.00M	USD	Annual
Salaries, wages and benefits	`LaborAndRelatedExpense`	$9.01B	USD	Annual
Salaries, wages and benefits	`LaborAndRelatedExpense`	$8.02B	USD	Annual
Salaries, wages and benefits	`LaborAndRelatedExpense`	$5.37B	USD	Annual
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$2.96B	USD	Annual
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$1.78B	USD	Annual
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$2.63B	USD	Annual
Other operating expenses, net	`OtherCostAndExpenseOperating`	$4.55B	USD	Annual
Other operating expenses, net	`OtherCostAndExpenseOperating`	$4.11B	USD	Annual
Other operating expenses, net	`OtherCostAndExpenseOperating`	$2.70B	USD	Annual
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$-72.00M	USD	Annual
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$-96.00M	USD	Annual
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$-104.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$797.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$849.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$545.00M	USD	Annual
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$103.00M	USD	Annual
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$318.00M	USD	Annual
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$153.00M	USD	Annual
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-291.00M	USD	Annual
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-31.00M	USD	Annual
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-25.00M	USD	Annual
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$186.00M	USD	Annual
Operating income	`OperatingIncomeLoss`	$1.06B	USD	Annual
Operating income	`OperatingIncomeLoss`	$925.00M	USD	Annual
Operating income	`OperatingIncomeLoss`	$663.00M	USD	Annual
Interest expense	`InterestExpense`	$912.00M	USD	Annual
Interest expense	`InterestExpense`	$474.00M	USD	Annual
Interest expense	`InterestExpense`	$754.00M	USD	Annual
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-24.00M	USD	Annual
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-348.00M	USD	Annual
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.00M	USD	Annual
Investment earnings	`GainLossOnInvestments`	$1.00M	USD	Annual
Investment earnings	`GainLossOnInvestments`	$1.00M	USD	Annual
Net income (loss) from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$144.00M	USD	Annual
Net income (loss) from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$147.00M	USD	Annual
Net income (loss) from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-158.00M	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-65.00M	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$68.00M	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$49.00M	USD	Annual
Net income (loss) from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-93.00M	USD	Annual
Net income (loss) from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$76.00M	USD	Annual
Net income (loss) from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$98.00M	USD	Annual
Loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$-17.00M	USD	Annual
Loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$-5.00M	USD	Annual
Loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$-5.00M	USD	Annual
Litigation and investigation costs	`DisposalGroupIncludingDiscontinuedOperationLitigationAndInvestigationExpense`	$-2.00M	USD	Annual
Litigation and investigation costs	`DisposalGroupIncludingDiscontinuedOperationLitigationAndInvestigationExpense`	$-18.00M	USD	Annual
Litigation and investigation costs	`DisposalGroupIncludingDiscontinuedOperationLitigationAndInvestigationExpense`	$8.00M	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$1.00M	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-13.00M	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$4.00M	USD	Annual
Net income (loss) from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-22.00M	USD	Annual
Net income (loss) from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-11.00M	USD	Annual
Net income (loss) from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$2.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$76.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$-104.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$78.00M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$64.00M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$218.00M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$30.00M	USD	Annual
Net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$12.00M	USD	Annual
Net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-134.00M	USD	Annual
Net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-140.00M	USD	Annual
Net income (loss) from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$-142.00M	USD	Annual
Net income (loss) from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$34.00M	USD	Annual
Net income (loss) from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$-123.00M	USD	Annual
Net income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-22.00M	USD	Annual
Net income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$2.00M	USD	Annual
Net income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-11.00M	USD	Annual
Net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$12.00M	USD	Annual
Net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-134.00M	USD	Annual
Net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-140.00M	USD	Annual
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.35	USD	Annual
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.43	USD	Annual
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.21	USD	Annual
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.11	USD	Annual
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.23	USD	Annual
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.02	USD	Annual
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$0.12	USD	Annual
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.41	USD	Annual
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.32	USD	Annual
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.21	USD	Annual
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.43	USD	Annual
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.34	USD	Annual
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.02	USD	Annual
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.22	USD	Annual
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.11	USD	Annual
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.41	USD	Annual
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.32	USD	Annual
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.12	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	99.17M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	101.65M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	97.80M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	100.29M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	101.65M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.17M	shares	Annual

Cash Flow Statement 135 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$76.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$-104.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$78.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$797.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$849.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$545.00M	USD	Annual
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.30B	USD	Annual
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.48B	USD	Annual
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$972.00M	USD	Annual
Deferred income tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$42.00M	USD	Annual
Deferred income tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$30.00M	USD	Annual
Deferred income tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$-67.00M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$36.00M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$51.00M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$69.00M	USD	Annual
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$103.00M	USD	Annual
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$318.00M	USD	Annual
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$153.00M	USD	Annual
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-291.00M	USD	Annual
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-31.00M	USD	Annual
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-25.00M	USD	Annual
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-24.00M	USD	Annual
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-348.00M	USD	Annual
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.00M	USD	Annual
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$186.00M	USD	Annual
Undistributed earnings from affiliates	`UndistributedEarnings`	$13.00M	USD	Annual
Undistributed earnings from affiliates	`UndistributedEarnings`	$10.00M	USD	Annual
Undistributed earnings from affiliates	`UndistributedEarnings`	$99.00M	USD	Annual
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$28.00M	USD	Annual
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$19.00M	USD	Annual
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$41.00M	USD	Annual
Pre-tax loss (income) from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-35.00M	USD	Annual
Pre-tax loss (income) from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-7.00M	USD	Annual
Pre-tax loss (income) from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$3.00M	USD	Annual
Other items, net	`OtherNoncashIncomeExpense`	$-59.00M	USD	Annual
Other items, net	`OtherNoncashIncomeExpense`	$30.00M	USD	Annual
Other items, net	`OtherNoncashIncomeExpense`	$20.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$987.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.90B	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.63B	USD	Annual
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$203.00M	USD	Annual
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$314.00M	USD	Annual
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$130.00M	USD	Annual
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	$-18.00M	USD	Annual
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	$-3.00M	USD	Annual
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$505.00M	USD	Annual
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$68.00M	USD	Annual
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$38.00M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$38.00M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$44.00M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$13.00M	USD	Annual
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$168.00M	USD	Annual
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$200.00M	USD	Annual
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$114.00M	USD	Annual
Net cash used in operating activities from discontinued operations, excluding income taxes	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-23.00M	USD	Annual
Net cash used in operating activities from discontinued operations, excluding income taxes	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-21.00M	USD	Annual
Net cash used in operating activities from discontinued operations, excluding income taxes	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-15.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$589.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$687.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.03B	USD	Annual
Purchases of property and equipment - continuing operations	`PaymentsToAcquirePropertyPlantAndEquipment`	$842.00M	USD	Annual
Purchases of property and equipment - continuing operations	`PaymentsToAcquirePropertyPlantAndEquipment`	$933.00M	USD	Annual
Purchases of property and equipment - continuing operations	`PaymentsToAcquirePropertyPlantAndEquipment`	$691.00M	USD	Annual
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.51B	USD	Annual
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$428.00M	USD	Annual
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$940.00M	USD	Annual
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$6.00M	USD	Annual
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$20.00M	USD	Annual
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$549.00M	USD	Annual
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$12.00M	USD	Annual
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$13.00M	USD	Annual
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$60.00M	USD	Annual
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$1.00M	USD	Annual
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$12.00M	USD	Annual
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$134.00M	USD	Annual
Other long-term assets	`PaymentsForProceedsFromProductiveAssets`	$-31.00M	USD	Annual
Other long-term assets	`PaymentsForProceedsFromProductiveAssets`	$4.00M	USD	Annual
Other long-term assets	`PaymentsForProceedsFromProductiveAssets`	$-8.00M	USD	Annual
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-1.00M	USD	Annual
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$6.00M	USD	Annual
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-3.00M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.32B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.16B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.32B	USD	Annual
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	$1.29B	USD	Annual
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	$2.81B	USD	Annual
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	$2.43B	USD	Annual
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	$2.25B	USD	Annual
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	$2.60B	USD	Annual
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	$1.69B	USD	Annual
Repayments of other borrowings	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$5.13B	USD	Annual
Repayments of other borrowings	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$683.00M	USD	Annual
Repayments of other borrowings	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$2.05B	USD	Annual
Proceeds from other borrowings	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	$1.61B	USD	Annual
Proceeds from other borrowings	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	$3.16B	USD	Annual
Proceeds from other borrowings	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	$6.51B	USD	Annual
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$400.00M	USD	Annual
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$40.00M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$80.00M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$154.00M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$27.00M	USD	Annual
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$45.00M	USD	Annual
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$27.00M	USD	Annual
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$110.00M	USD	Annual
Contributions from noncontrolling interests	`ProceedsFromMinorityShareholders`	$4.00M	USD	Annual
Contributions from noncontrolling interests	`ProceedsFromMinorityShareholders`	$99.00M	USD	Annual
Contributions from noncontrolling interests	`ProceedsFromMinorityShareholders`	$18.00M	USD	Annual
Purchase of noncontrolling interest	`PaymentsForRepurchaseOfRedeemableNoncontrollingInterest`	$254.00M	USD	Point-in-time
Purchase of noncontrolling interest	`PaymentsForRepurchaseOfRedeemableNoncontrollingInterest`	$254.00M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$26.00M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$15.00M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$22.00M	USD	Annual
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$5.00M	USD	Annual
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$3.00M	USD	Annual
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$30.00M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.32B	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$715.00M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$454.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$163.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-251.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$80.00M	USD	Annual
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$356.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$193.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$364.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$113.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$356.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$193.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$364.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$113.00M	USD	Point-in-time
Interest paid, net of capitalized interest	`InterestPaidNet`	$726.00M	USD	Annual
Interest paid, net of capitalized interest	`InterestPaidNet`	$426.00M	USD	Annual
Interest paid, net of capitalized interest	`InterestPaidNet`	$859.00M	USD	Annual
Income tax payments, net	`IncomeTaxesPaidNet`	$-6.00M	USD	Annual
Income tax payments, net	`IncomeTaxesPaidNet`	$-7.00M	USD	Annual
Income tax payments, net	`IncomeTaxesPaidNet`	$-8.00M	USD	Annual

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.22B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$958.00M	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$785.00M	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$878.00M	USD	Point-in-time
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-113.00M	USD	Annual
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$43.00M	USD	Annual
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-88.00M	USD	Annual
Distributions paid to noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$50.00M	USD	Annual
Distributions paid to noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$37.00M	USD	Annual
Distributions paid to noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$22.00M	USD	Annual
Contributions from noncontrolling interests	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$105.00M	USD	Annual
Contributions from noncontrolling interests	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$3.00M	USD	Annual
Contributions from noncontrolling interests	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$7.00M	USD	Annual
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$-158.00M	USD	Annual
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$44.00M	USD	Annual
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$18.00M	USD	Annual
Purchases (sales) of businesses and noncontrolling interests	`AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest`	$252.00M	USD	Annual
Purchases (sales) of businesses and noncontrolling interests	`AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest`	$-12.00M	USD	Annual
Repurchases of common stock	`StockRepurchasedDuringPeriodValue`	$40.00M	USD	Annual
Repurchases of common stock	`StockRepurchasedDuringPeriodValue`	$400.00M	USD	Annual
Stock-based compensation expense and issuance of common stock	`StockIssuedDuringPeriodValueShareBasedCompensation`	$78.00M	USD	Annual
Stock-based compensation expense and issuance of common stock	`StockIssuedDuringPeriodValueShareBasedCompensation`	$64.00M	USD	Annual
Stock-based compensation expense and issuance of common stock	`StockIssuedDuringPeriodValueShareBasedCompensation`	$46.00M	USD	Annual
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.22B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$958.00M	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$785.00M	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$878.00M	USD	Point-in-time

Comprehensive Income 29 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$76.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$-104.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$78.00M	USD	Annual
Adjustments for defined benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax`	$-62.00M	USD	Annual
Adjustments for defined benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax`	$258.00M	USD	Annual
Adjustments for defined benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax`	$-3.00M	USD	Annual
Amortization of net actuarial loss included in net periodic benefit costs	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$7.00M	USD	Annual
Amortization of net actuarial loss included in net periodic benefit costs	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$12.00M	USD	Annual
Amortization of net actuarial loss included in net periodic benefit costs	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$4.00M	USD	Annual
Unrealized gains (losses) on securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-2.00M	USD	Annual
Unrealized gains (losses) on securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$3.00M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$5.00M	USD	Annual
Other comprehensive income (loss) before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$69.00M	USD	Annual
Other comprehensive income (loss) before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$-251.00M	USD	Annual
Other comprehensive income (loss) before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$18.00M	USD	Annual
Income tax benefit (expense) related to items of other comprehensive income (loss)	`OtherComprehensiveIncomeLossTax`	$-93.00M	USD	Annual
Income tax benefit (expense) related to items of other comprehensive income (loss)	`OtherComprehensiveIncomeLossTax`	$25.00M	USD	Annual
Total other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-158.00M	USD	Annual
Total other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$44.00M	USD	Annual
Total other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$18.00M	USD	Annual
Comprehensive net income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-82.00M	USD	Annual
Comprehensive net income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$96.00M	USD	Annual
Comprehensive net income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-60.00M	USD	Annual
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$30.00M	USD	Annual
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$64.00M	USD	Annual
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$218.00M	USD	Annual
Comprehensive net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-146.00M	USD	Annual
Comprehensive net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-122.00M	USD	Annual
Comprehensive net income available (loss attributable) to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-90.00M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.